S&P 500 7,649.46 −1.39%
Nasdaq 26,029.48 −2.52%
S&P/TSX 35,922.10 −1.11%
Apple 345.91 +0.56%
Nvidia 212.42 −4.30%
Microsoft 524.09 −1.66%
Shopify 235.60 −3.81%
Royal Bank 282.69 −0.33%
CAD/USD 0.7137 +0.39%
LIVE · 13:10 ET
Market ClerkRecap
Thu Oct 22 · markets open6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead
TA
INSIDER · KROS · Keros Therapeutics, Inc. · CORP. CONTROLLER & VP, FINANCE

Tanini Annita

Every open-market transaction filed under this name, Aug 18 to Aug 18.

Filings
1
0 buys · 1 sell
Bought
—
open market, at cost
Sold
$13K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 18KROSKeros Therapeutics, Inc.Corp. Controller & VP, FinanceSell1,224$10.29$13K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.